Immunohistochemical expression of Ki67 as direct visualization of proliferating cells [17], is not a criterion for pathological grading but has long been suggested as a prognostic marker in meningioma [18] and the increased risk of tumor recurrence in WHO grade I meningiomas based on increased Ki67 expression has recently been demonstrated [19]. This evidence concerns the gene MKI67 and neoplasm.